NCT05667064 Imfinzi/Imjudo uHCC Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study Status COMPLETED Phase N/A
NCT05665374 Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study Status COMPLETED Phase N/A
NCT05663957 eVusheld Assessment reaL wORld Effectiveness in the VA Health System Status COMPLETED Phase N/A
NCT05663515 A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs Status RECRUITING Phase N/A
NCT05662033 A Study to Investigate the Safety, Tolerability, and Pharmacokinetics (PK) of Oral AZD6793 in Healthy and Chronic Obstructive Pulmonary Disease Participants, to Assess the Relative Oral Bioavailability Between Two Formulations, and the Food Effect on the PK of AZD6793 Compared to Fasting State. Status COMPLETED Phase PHASE1
NCT05659914 Olaparib and Durvalumab (MEDI4736) in Patients with Metastatic Pancreatic Cancer and DNA Damage Repair Genes Alterations Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05648110 Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study Status COMPLETED Phase PHASE2/PHASE3
NCT05645172 Retention Rate of Acalabrutinib in a Non-interventional Setting Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05644600 A Study to Assess the Effect of AZD5055 on the Pharmacokinetics (PK) of Nintedanib in Healthy Participants. Status TERMINATED Phase PHASE1
NCT05638737 A Study in Participants With Non-cirrhotic NASH With Fibrosis Status COMPLETED Phase PHASE2
NCT05637112 A Treatment Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05635331 Real-world Dapagliflozin Experience in Patients With Heart Failure in Greece Status COMPLETED Phase N/A
NCT05630677 A Study to Compare Bioavailability of AZD5055 Film-coated Tablet With AZD5055 Oral Suspension and to Assess the Effect of Food and an Acid Reducing Agent on Pharmacokinetics (PK) of AZD5055 in Healthy Subjects. Status COMPLETED Phase PHASE1
NCT05629585 A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05629234 Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Osimertinib (TAGRISSO) (ROSY-T) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05624450 Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen Status RECRUITING Phase PHASE3
NCT05617963 Durvalumab Maintenance After Thoracic Chemoradiotherapy in Frail Small Cell Lung Cancer Patients Whose Disease is Limited to the Thorax Status ACTIVE_NOT_RECRUITING Phase PHASE2